Epidermodysplasia verruciformis: clinical regression and increased cellular immunity induced by OK 432 treatment.
作者信息
Yambe H, Oikawa O, Jimbow K
出版信息
J Dermatol. 1985 Apr;12(2):183-90. doi: 10.1111/j.1346-8138.1985.tb01557.x.
Abstract
摘要
相似文献
1
Epidermodysplasia verruciformis: clinical regression and increased cellular immunity induced by OK 432 treatment.
J Dermatol. 1985 Apr;12(2):183-90. doi: 10.1111/j.1346-8138.1985.tb01557.x.
2
Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
Dermatologica. 1985;170(5):213-20. doi: 10.1159/000249535.
3
Throwing off warts.去除疣
Br Med J. 1978 Aug 19;2(6136):521-2.
4
Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon.疣状表皮发育不良中疣对全身及皮损内注射α干扰素治疗的反应
J Am Acad Dermatol. 1984 Aug;11(2 Pt 1):197-202. doi: 10.1016/s0190-9622(84)70149-6.
5
Concepts of wart regression.
Arch Dermatol. 1986 Jun;122(6):644-7.
6
Persistent warts protected from immune attack by a blocking factor.
Br J Dermatol. 1979 Jun;100(6):731-3. doi: 10.1111/j.1365-2133.1979.tb08081.x.
7
[Response to OK-432 (picibanil) in cancer patients and change of immunological parameters for the administration of OK-432 (picibanil)].[癌症患者对OK-432（溶链菌制剂）的反应及OK-432（溶链菌制剂）给药后免疫参数的变化]
Nihon Jibiinkoka Gakkai Kaiho. 1988 Feb;91(2):215-24. doi: 10.3950/jibiinkoka.91.215.
8
[Effect of an immunomodifier on radiation-induced antitumor immunity following local irradiation of the tumor--1. OK-432].免疫调节剂对肿瘤局部照射后辐射诱导的抗肿瘤免疫的影响——1. 溶链菌制剂
Nihon Igaku Hoshasen Gakkai Zasshi. 1987 Jun 25;47(6):838-44.
9
[The effect of OK-432 in the treatment of primary lung cancer].[溶链菌制剂对原发性肺癌的治疗作用]
Gan To Kagaku Ryoho. 1987 Apr;14(4):1051-6.
10
Regression of the lesions of epidermodysplasia verruciformis.疣状表皮发育不良病变的消退
Br J Dermatol. 1982 Jul;107(1):109-15. doi: 10.1111/j.1365-2133.1982.tb00298.x.
Zotero 插件